Scipio bioscience, an early-stage company that develops products for single-cell sample preparation and data analysis, has announced that Asteria, a single-cell RNA-sequencing kit, is now commercially available to researchers globally.
The hydrogel-based benchtop kit enables the transcriptomic profiling of 10,000 individual cells per sample, instrument-free, at an affordable price, said the developer.
It allows genomics researchers to perform straightforward, instrument-free single-cell cDNA preparation at their workbench to achieve high mRNA capture and gene sensitivity with low multiplet rates, it added.
Researchers also gain access to Scipio’s analysis software, Cytonaut, which, it explained, is an end-to-end tool, covering pre- and post-processing analysis, as well as interactive data visualization and generation of publication-ready results and figures. “Hosted in a secure cloud infrastructure, it guides the user through the analysis step by step, enables researchers to free themselves from heavy computing resources and let them exploit their data without prerequired knowledge in bioinformatics.”
The combination of the kit and software is a comprehensive end-to-end single-cell solution – sequencing excepted – accessible to any scientist with or without prior knowledge of single-cell technology and bioinformatics, said the firm.
“We are achieving our goal of bringing a single-cell solution to every lab, empowering researchers to use single-cell sequencing unhindered by the technical, logistical and cost limitations of current solutions. With the Asteria kit ready in the freezer for on-the-spot profiling and cloud-based Cytonaut accessible from any computer for immediate bioinformatic analysis, anyone can start generating high-quality single-cell data on their own terms,” said Pierre Walrafen, CEO, Scipio bioscience.